This is an IRB-approved multicenter study.This non-inferiority study aims to evaluate differential healing rates between Lavior Diabetic Wound Gel and other Hydrogels. Study therapy will be started in the outpatient setting and followed accordingly.
1 Primary · 6 Secondary · Reporting Duration: 60 Days
Active Control
100 Total Participants · 2 Treatment Groups
Primary Treatment: TRIAL INTERVENTION · No Placebo Group · Phase 2 & 3
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: